Compounds > cyclosporine

cyclosporine and Mucopolysaccharidosis I

cyclosporine has been researched along with Mucopolysaccharidosis I in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dickson, P; Jabagat, C; Kakkis, ED; Krieger, A; Le, S; Lester, T; Manuel, H; McEntee, M; Passage, M; Peinovich, M1
Ponder, KP1
Brown, JR; Crawford, BE; Dickson, PI; Ellinwood, NM; Le, SQ; Passage, MB; Vera, MU; Witt, RG1
Anand, V; Kakkis, E; Lemontt, J; Lester, T; Passage, M; Peinovich, M; Tanaka, C; Yang, R1

Other Studies

4 other study(ies) available for cyclosporine and Mucopolysaccharidosis I

ArticleYear
Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
    The Journal of clinical investigation, 2008, Volume: 118, Issue:8

    Topics: Animals; Azathioprine; Cyclosporine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Glycosaminoglycans; Humans; Iduronidase; Immune Tolerance; Immunosuppressive Agents; Kidney; Lysosomal Storage Diseases; Lysosomes; Mitral Valve; Mucopolysaccharidosis I; Recombinant Proteins; Synovial Membrane; Time Factors

2008
Immune response hinders therapy for lysosomal storage diseases.
    The Journal of clinical investigation, 2008, Volume: 118, Issue:8

    Topics: Animals; Antibodies; Azathioprine; Cyclosporine; Dogs; Iduronidase; Immune Tolerance; Immunosuppressive Agents; Lysosomal Storage Diseases; Models, Immunological; Mucopolysaccharidosis I; Time Factors

2008
Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.
    Molecular genetics and metabolism, 2012, Volume: 106, Issue:1

    Topics: Animals; Antibody Specificity; Brain; Cyclosporine; Disease Models, Animal; Dogs; Enzyme Replacement Therapy; Glycosaminoglycans; Humans; Iduronidase; Immune Tolerance; Immunoglobulin G; Immunosuppressive Agents; Injections, Spinal; Mucopolysaccharidosis I

2012
Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Jan-20, Volume: 101, Issue:3

    Topics: Animals; Azathioprine; Cyclosporine; Disease Models, Animal; Dogs; Humans; Iduronidase; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Mucopolysaccharidosis I; Receptor, IGF Type 2; Recombinant Proteins

2004